Novem Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$250K Hold
2,725
0.03% 386
2026
Q1
$232K Buy
2,725
+14
+0.5% +$1.25K 0.03% 384
2025
Q4
$214K Buy
2,711
+38
+1% +$2.98K 0.02% 394
2025
Q3
$214K Sell
2,673
-24
-0.9% -$2.05K 0.03% 388
2025
Q2
$245K Buy
2,697
+9
+0.3% +$822 0.03% 349
2025
Q1
$252K Buy
2,688
+15
+0.6% +$1.34K 0.04% 313
2024
Q4
$243K Buy
+2,673
New +$255K 0.04% 315

Other funds holding CL

Novem Group's CL Position: Q2 2026 in Review

Novem Group held its Colgate-Palmolive (CL) position steady in Q2 2026 at 2,725 shares worth $250K. The position accounts for 0.03% of the portfolio, ranked #386.

Novem Group first reported a position in CL in Q4 2024 and has held it in 7 quarters since. The position peaked at $252K in Q1 2025. 600 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Novem Group held 2,725 shares of Colgate-Palmolive worth $250K as of Q2 2026.
  • Novem Group left its Colgate-Palmolive share count unchanged in Q2 2026.
  • Colgate-Palmolive made up 0.03% of Novem Group's portfolio in Q2 2026, its #386 holding.
  • Novem Group first reported a position in Colgate-Palmolive in Q4 2024 and has held it in 7 quarters since.
  • Novem Group's Colgate-Palmolive position peaked at $252K in Q1 2025.
  • 600 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Novem Group's 13F filing for Q2 2026, filed 21 Jul 2026.